Pharmaceutical Analysis of Eptifibatide via Simple, Rapid, Economical UV-Spectrophotometric Methods

Published: May 20, 2015

Authors

  • Sushant S. Patil R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, India
  • Saurabh B. Ganorkar R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, India
  • Atul A. Shirkhedkar R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, India
Keywords
Eptifibatide, UV-Spectrophotometry, First Order Derivative-AUC

Abstract

Eptifibatide is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Pharmaceutically it is applied to reduce the risk of acute cardiac ischemic events. The present work reveals two simple, rapid and economical UuV-Spectrophotometric methods for pharmaceutical analysis of Eeptifibatide bulk and in parenteral formulation. The ‘Method I’ is based on the Zero Order Spectrophotometric determination of drug at its wavelength maximum 218.20 nm and ‘Method II’ employed First Order Derivative – Aarea Uunder Curve (AUauC) technique in which the area has been integrated between two wavelengths 220.20 to 237.20 nm. The drug obeyed linearity in the concentration range of 3 – 18 μg/mLl with coefficient of correlation; greater than 0.999 in both methods. The amounts of drug determined by both methods are in conformity with label claim. These methods are validated for accuracy, precision and ruggedness with % RSD value less than 2.0.

References

  • Hantgan, R., Rocco, M., Nagaswami, C., Weisel, J., et al. (2001), Binding of a fibrinogen mimetic stabilizes integrin αIIbβ3’s open conformotion, Protein Science, 10(8), 1614-1626. http://dx.doi.org/10.1110/ps.3001
  • ICH Harmonized Tripartite Guideline, Q2 (R1): Validation of Analytical Procedures: Text and Methodology. November 2005.
  • Kachhadia, P., (2008), Studies on synthesis of bioactive compounds and HPLC profile of some pharmaceutical formulation, thesis PhD, Saurashtra University, Rajkot, India.
  • Katori, N., Szlam, F., Levy, S., Tanaka, K., et al. (2004), A novel method to assess platelet inhibition by Eptifibatide with Thrombelastograph, Anesthesia & Analgesia, 99(6), 1794-1799. http://dx.doi.org/10.1213/01.ANE.0000136476.82598.88
  • Liu, Z., Duan, X., Chen, X., Zhong, D., et al (2009), Determination of Eptifibatide concentration in human plasma utilizing the liquid chromatography-tandem mass spectrometry method, Journal of chromatography B, 877( 5-6), 527-532.
  • The Merck Index – An Encyclopedia of Chemicals, Drugs and Biologicals, 14th edn, Merck Research Laboratories, Whitehouse Station, New Jersey, USA, 2006, 6247.
  • Yu, X., Zhou, Z., Yang, M., Mai, L., Lin, Q., Deng, C., Shan, Z., Kuang, S., Zhu, P., Huang, X., Li, X., Chen, T., Lin, S., (2010), Improved liquid chromatography-tandem mass spectrometry method for the analysis of Eptifibatide in human plasma, Journal of chromatography B, 878(23), 2094-2100. http://dx.doi.org/10.1016/j.jchromb.2010.06.012

How to Cite

Sushant S. Patil, Saurabh B. Ganorkar, Atul A. Shirkhedkar. Pharmaceutical Analysis of Eptifibatide via Simple, Rapid, Economical UV-Spectrophotometric Methods. J. Pharm. Technol. Res. Manag.. 2015, 03, 49-55
Pharmaceutical Analysis of Eptifibatide via Simple, Rapid, Economical UV-Spectrophotometric Methods

Current Issue

PeriodicityBiannually
Issue-1May
Issue-2November
ISSN Print2321-2217
ISSN Online2321-2225
RNI No.CHAENG/2013/50088
OA Policy

Publisher's policy of the journal at Sherpa UK for the submitted, accepted, and published articles. Click OAPolicy

Plan-S Compliance

To check compliance, one has to use the Journal Check Tool (JCT). This tool provided by cOAlition S (European funders) for the researchers (fundee) to check the compliance with the journal.

Recommend journal to your library

You can recommend the journal being a researcher or faculty member to your library. We will post a copy of the Journal to your library on your behalf at free of cost.
Click here: Recommend Journal

Preprint Arxiv Submission

The authors are encouraged to submit the author’s copy (preprint) to appropriate preprint archives e.g. https://arxiv.org and/or on https://indiarxiv.org or institutional repositories (e.g., D Space) before paper acceptance by the editor of Journal. After publications of the paper author(s) should mention the citation information, title and abstract along with DOI number of the publication carefully on the required page of the depository(ies).

Contact: Phone: +91-172-2741000, +91-172-4691800

Email : editor.jptrm@chitkara.edu.in;

Abstract and Indexing

Information

This work is licensed under a Creative Commons Attribution 4.0 International License.

Articles in Journal of Pharmaceutical Technology, Research and Management (J. Pharm. Tech. Res. Management) by Chitkara University Publications are Open Access articles that are published with licensed under a Creative Commons Attribution- CC-BY 4.0 International License. Based on a work at https://jptrm.chitkara.edu.in/. This license permits one to use, remix, tweak and reproduction in any medium, even commercially provided one give credit for the original creation.

View Legal Code of the above-mentioned license, https://creativecommons.org/licenses/by/4.0/legalcode

View Licence Deed here https://creativecommons.org/licenses/by/4.0/

Creative Commons License

Journal of Pharmaceutical Technology, Research and Management by Chitkara University Publications is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at https://jptrm.chitkara.edu.in//

Members